Skip to content

Zymergen Inc.

Delisted

CIK 1645842fmd_0M2JQ75D6BVJAV4SGZ0957SQPGServices · Services-Commercial Physical & Biological ResearchTemplate: Standard

Coverage: Jan 01, 2019 to Jun 30, 2022, 11 periods

Latest annual · FY2021

Millions
Total revenues
17
Gross profit
(53)
Operating income
(348)
Net income
(362)
Free cash flow
(336)

Latest quarter · Q2 FY2022

Millions
Total revenues
3
Gross profit
(8)
Operating income
(106)
Net income
(116)
Free cash flow
(63)
Open Financials

Zymergen Inc. financials: quick answers

Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.

MetricFY2021FY2020ChangeSource
Revenue$16.7 million$13.3 million+26%10-K 2022-03-30 · proof
Gross profit-$53 million-$71.5 million10-K 2022-03-30 · proof
Operating income-$347.6 million-$241.1 million10-K 2022-03-30 · proof
Net income-$361.8 million-$262.2 million10-K 2022-03-30 · proof
Cash from operating activities-$302.5 million-$223.2 million10-K 2022-03-30 · proof
Free cash flow-$335.9 million-$240.4 million10-K 2022-03-30 · proof
Total assets$522.4 million$304.9 million+71.3%10-K 2022-03-30 · proof
Total liabilities$113.9 million$147.9 million-23%10-K 2022-03-30 · proof
Cash and cash equivalents$386.1 million$210.2 million+83.7%10-K 2022-03-30 · proof
Total debt$44 million$79.3 million-44.6%10-K 2022-03-30 · proof
What was Zymergen Inc.'s revenue in fiscal 2021?
Zymergen Inc. reported revenue of $16.7 million for fiscal 2021 (the year ended Dec 31, 2021), against $13.3 million the year before (+26%). Source: the 10-K filed with the SEC on Mar 30, 2022. SEC
What was Zymergen Inc.'s gross profit in fiscal 2021?
Zymergen Inc. reported gross profit of -$53 million for fiscal 2021 (the year ended Dec 31, 2021), against -$71.5 million the year before. Source: the 10-K filed with the SEC on Mar 30, 2022. SEC
What was Zymergen Inc.'s operating income in fiscal 2021?
Zymergen Inc. reported operating income of -$347.6 million for fiscal 2021 (the year ended Dec 31, 2021), against -$241.1 million the year before. Source: the 10-K filed with the SEC on Mar 30, 2022. SEC
What was Zymergen Inc.'s net income in fiscal 2021?
Zymergen Inc. reported net income of -$361.8 million for fiscal 2021 (the year ended Dec 31, 2021), against -$262.2 million the year before. Source: the 10-K filed with the SEC on Mar 30, 2022. SEC
What was Zymergen Inc.'s cash from operating activities in fiscal 2021?
Zymergen Inc. reported cash from operating activities of -$302.5 million for fiscal 2021 (the year ended Dec 31, 2021), against -$223.2 million the year before. Source: the 10-K filed with the SEC on Mar 30, 2022. SEC
What was Zymergen Inc.'s free cash flow in fiscal 2021?
Zymergen Inc. reported free cash flow of -$335.9 million for fiscal 2021 (the year ended Dec 31, 2021), against -$240.4 million the year before. Source: the 10-K filed with the SEC on Mar 30, 2022. SEC
What are Zymergen Inc.'s total assets?
As of Dec 31, 2021, Zymergen Inc. reported total assets of $522.4 million, against $304.9 million a year earlier (+71.3%). Source: the 10-K filed with the SEC on Mar 30, 2022. SEC
What are Zymergen Inc.'s total liabilities?
As of Dec 31, 2021, Zymergen Inc. reported total liabilities of $113.9 million, against $147.9 million a year earlier (-23%). Source: the 10-K filed with the SEC on Mar 30, 2022. SEC
What are Zymergen Inc.'s cash and cash equivalents?
As of Dec 31, 2021, Zymergen Inc. reported cash and cash equivalents of $386.1 million, against $210.2 million a year earlier (+83.7%). Source: the 10-K filed with the SEC on Mar 30, 2022. SEC
What is Zymergen Inc.'s total debt?
As of Dec 31, 2021, Zymergen Inc. reported total debt of $44 million, against $79.3 million a year earlier (-44.6%). Source: the 10-K filed with the SEC on Mar 30, 2022. SEC

Read from the FinancialMD API on Nov 14, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.

The same numbers for an agent, with proof on every value:

curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:1645842&period_type=annual&limit=5"

Information only, not investment advice.